Intuitive Surgical Competitors & Alternatives
Intuitive Surgical competitors and alternatives include Becton, Dickinson and Company, etc.…
Jump
-
Stock Price
-
Market Cap
-
Employees
-
Income Statement
-
Revenue
-
Revenue by Product / Services
-
Revenue by Geography
-
Research and Development
-
Operating Income
-
Tax Rate (%)
-
Net Income
-
Assets & Liabilities | Cash Flow
-
Total Assets
-
Total Liabilities
-
Capital Expenditures (Capex)
-
Profitability
-
Operating Income Margin (%)
-
Net Income Margin (%)
-
EBITDA
-
Free Cash Flow (FCF)
-
Ratios
-
Return on Equity (ROE)
-
Return on Assets (ROA)
-
Debt to Equity
-
Valuation
-
Enterprise value
-
Enterprise value to Revenue
-
Enterprise value to EBITDA
Ticker
ISRG
BDX
Headquarter
Sunnyvale
,CA
US
Franklin Lakes
,NJ
US
CEO
Industry
Medical - Instruments & Supplies
Medical - Instruments & Supplies
Stock Price
Stock Price
Market Cap
Market Cap
$200.70 B
$57.97 B
Employees
Years
- 2023
- 2024
- 2025
- 2023
- 2024
- 2025
Employees
- 12.12 K
- 13.68 K
- 15.64 K
- 73.00 K
- 74.00 K
- 72.00 K
Y/Y
23.76%
12.84%
14.35%
5.19%
1.37%
2.7%
Income Statement
Revenue
Years
- 2022
- 2023
- 2024
- 2023
- 2024
- 2025
Revenue
- $6.22 B
- $7.12 B
- $8.35 B
- $19.37 B
- $20.18 B
- $21.84 B
Y/Y
8.97%
14.49%
17.24%
2.66%
4.16%
8.23%
Revenue by Products / Services
Years
- 2024
- 2024
Revenue by Geography
Years
- 2025
- 2024
Research and Development
Years
- 2022
- 2023
- 2024
- 2023
- 2024
- 2025
Research and Development
- $879.00 M
- $998.80 M
- $1.15 B
- $1.24 B
- $1.19 B
- $1.26 B
Y/Y
31%
13.63%
14.67%
1.51%
3.8%
6.22%
Operating Income
Years
- 2022
- 2023
- 2024
- 2023
- 2024
- 2025
Operating Income
- $1.58 B
- $1.77 B
- $2.35 B
- $2.11 B
- $2.40 B
- $2.58 B
Y/Y
13.39%
12.03%
32.95%
7.49%
13.55%
7.55%
Tax Rate (%)
Years
- 2022
- 2023
- 2024
- 2023
- 2024
- 2025
Tax Rate (%)
- 16.33%
- 7.23%
- 12.58%
- 7.94%
- 14.96%
- 10.84%
Y/Y
90.32%
55.74%
74%
4.32%
88.39%
27.56%
Net Income
Years
- 2022
- 2023
- 2024
- 2023
- 2024
- 2025
Net Income
- $1.32 B
- $1.80 B
- $2.32 B
- $1.48 B
- $1.71 B
- $1.68 B
Y/Y
22.43%
35.98%
29.18%
16.58%
14.89%
1.58%
Revenue Per Employee
Years
- 2023
- 2024
- 2025
- 2023
- 2024
- 2025
Revenue Per Employee
- $587.80 K
- $610.71 K
- -
- $265.37 K
- $272.68 K
- $303.32 K
Y/Y
7.49%
3.9%
100%
8.29%
2.75%
11.24%
Net Income Per Employee
Years
- 2023
- 2024
- 2025
- 2023
- 2024
- 2025
Net Income Per Employee
- $148.35 K
- $169.83 K
- -
- $20.33 K
- $23.04 K
- $23.31 K
Y/Y
9.87%
14.48%
100%
12.01%
13.34%
1.15%
Assets & Liabilities | Cash Flow
Total Assets
Years
- 2022
- 2023
- 2024
- 2023
- 2024
- 2025
Total Assets
- $12.97 B
- $15.44 B
- $18.84 B
- $52.78 B
- $57.29 B
- $55.33 B
Y/Y
4.29%
19.02%
22%
0.29%
8.54%
3.42%
Total Liabilities
Years
- 2022
- 2023
- 2024
- 2023
- 2024
- 2025
Total Liabilities
- $1.86 B
- $2.04 B
- $2.31 B
- $26.98 B
- $31.40 B
- $29.94 B
Y/Y
16.08%
9.82%
12.95%
2.42%
16.36%
4.65%
Capital Expenditures (Capex)
Years
- 2022
- 2023
- 2024
- 2023
- 2024
- 2025
Capital Expenditures (Capex)
- -$532.40 M
- -$1.06 B
- -$1.11 B
- -$874.00 M
- -$725.00 M
- -$760.00 M
Y/Y
50.61%
99.89%
4.42%
10.17%
17.05%
4.83%
Profitability
Operating Income Margin (%)
Years
- 2022
- 2023
- 2024
- 2023
- 2024
- 2025
Operating Income Margin (%)
- 25.35%
- 24.80%
- 28.12%
- 10.90%
- 11.88%
- 11.80%
Y/Y
20.52%
2.15%
13.4%
9.89%
9.01%
0.63%
Net Income Margin (%)
Years
- 2022
- 2023
- 2024
- 2023
- 2024
- 2025
Net Income Margin (%)
- 21.25%
- 25.24%
- 27.81%
- 7.66%
- 8.45%
- 7.68%
Y/Y
28.81%
18.76%
10.18%
18.74%
10.3%
9.07%
EBITDA
| 2021 | 2131200000.00 |
|---|---|
| 2022 | 1942900000.00 |
| 2023 | 2169000000.00 |
| 2024 | 2810900000.00 |
| 2022 | 4410000000.00 |
|---|---|
| 2023 | 4402000000.00 |
| 2024 | 4819000000.00 |
| 2025 | 4957000000.00 |
Years
- 2022
- 2023
- 2024
- 2023
- 2024
- 2025
EBITDA
- $1.94 B
- $2.17 B
- $2.81 B
- $4.40 B
- $4.82 B
- $4.96 B
Y/Y
8.84%
11.64%
29.59%
0.18%
9.47%
2.86%
Free Cash Flow (FCF)
| 2021 | 1735900000.00 |
|---|---|
| 2022 | 958400000.00 |
| 2023 | 749600000.00 |
| 2024 | 1303800000.00 |
| 2022 | 1660000000.00 |
|---|---|
| 2023 | 2115000000.00 |
| 2024 | 3072000000.00 |
| 2025 | 2670000000.00 |
Years
- 2022
- 2023
- 2024
- 2023
- 2024
- 2025
Free Cash Flow (FCF)
- $958.40 M
- $749.60 M
- $1.30 B
- $2.12 B
- $3.07 B
- $2.67 B
Y/Y
44.79%
21.79%
73.93%
27.41%
45.25%
13.09%
Ratios
Return on Equity (ROE)
Years
- 2022
- 2023
- 2024
- 2023
- 2024
- 2025
Return on Equity (ROE)
- 11.98%
- 13.51%
- 14.13%
- 5.75%
- 6.59%
- 0.00%
Y/Y
16.04%
12.82%
4.6%
18.25%
14.48%
100%
Return on Assets (ROA)
Years
- 2022
- 2023
- 2024
- 2023
- 2024
- 2025
Return on Assets (ROA)
- 10.19%
- 11.64%
- 12.33%
- 2.81%
- 2.98%
- 0.00%
Y/Y
18.95%
14.25%
5.88%
16.34%
5.85%
100%
Debt to Equity
Years
- 2022
- 2023
- 2024
- 2023
- 2024
- 2025
Debt to Equity
- 0.00%
- 0.00%
- 0.89%
- 61.55%
- 77.68%
- 75.55%
Y/Y
100%
0%
100%
3.13%
26.2%
2.75%
Valuation
Enterprise Value
Years
- 2022
- 2023
- 2024
- 2023
- 2024
- 2025
Enterprise value
- $92.80 B
- $115.73 B
- $183.52 B
- $88.48 B
- $89.06 B
- $0.00
Y/Y
26.78%
24.7%
58.57%
12.61%
0.67%
100%
Enterprise value to Revenue
Years
- 2022
- 2023
- 2024
- 2023
- 2024
- 2025
Enterprise value to Revenue
- 14.91
- 16.24
- 21.97
- 4.57
- 4.41
- 0.00
Y/Y
32.8%
8.92%
35.26%
9.69%
3.36%
100%
Enterprise value to EBITDA
Years
- 2022
- 2023
- 2024
- 2023
- 2024
- 2025
Enterprise value to EBITDA
- 47.77
- 53.36
- 65.29
- 20.10
- 18.48
- 0.00
Y/Y
19.68%
11.71%
22.36%
12.82%
8.05%
100%





